Consonance Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,799,916
| Closed | -$122M | – | 33 |
|
|
2019
Q2 | $122M | Sell |
2,799,916
-852,218
| -23% | -$37.1M | 8.62% | 4 |
|
|
2019
Q1 | $139M | Hold |
3,652,134
| – | – | 8.77% | 3 |
|
|
2018
Q4 | $157M | Hold |
3,652,134
| – | – | 11.56% | 1 |
|
|
2018
Q3 | $180M | Sell |
3,652,134
-101,700
| -3% | -$5M | 9.67% | 1 |
|
|
2018
Q2 | $120M | Buy |
3,753,834
+1,118,918
| +42% | +$35.9M | 7.76% | 3 |
|
|
2018
Q1 | $82.1M | Buy |
2,634,916
+1,032,582
| +64% | +$32.2M | 7.5% | 5 |
|
|
2017
Q4 | $73.1M | Buy |
1,602,334
+222,200
| +16% | +$10.1M | 6.61% | 8 |
|
|
2017
Q3 | $51.8M | Buy |
+1,380,134
| New | +$51.8M | 5.73% | 10 |
|
|
2017
Q2 | – | Sell |
-972,535
| Closed | -$44.3M | – | 22 |
|
|
2017
Q1 | $44.3M | Buy |
972,535
+340,730
| +54% | +$15.5M | 4.65% | 11 |
|
|
2016
Q4 | $20.4M | Buy |
+631,805
| New | +$20.4M | 2.24% | 16 |
|